LiveDNA empowers researchers, scholars, editors, reviewers, publishers, and institutions with a trusted digital identity and comprehensive professional profile.
Sameer E. Al-Harthi

Sameer E. Al-Harthi

LiveDNA ID: 966.31067
28 Publications
0 Editorial Roles
0 Projects

Education

Academic Background
  • Ph.D. University of Glasgow, UK Clinical Pharmacology | Completed: 2011

Publications (28)

Selected Scholarly Contributions
Neuroprotective effect of different doses of vitamine D3 in diabetic-induced Alzheimer rat model.
Al-Zahrani, Y.A., M.A.A.A. Sattar, S.E. Al-Harthi and H.M. Alkreathy,
J. Pharmaceut. Res. Int., | Journal Article
Self Sameer E. Al-Harthi
2019
Neuroprotective role of vitamin D3 against insulin resistance and diabetic induced memory dysfunction in rats.
Al-Zahrani, Y.A., M.A.A.A. Sattar, S.E. Alharthi and H.M. Alkreathy,
Int. J. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2019
Cardioprotective effect of marine astaxanthin on doxorubicin-induced cardiotoxicity in normal rats.
AlQahtani, A.A., A.M.M. Osman, Z.A. Damanhouri, H.M. Al-Kreathy and H.S. Al-Malky et al.,
J. Pharm. Res. Int., | Journal Article
Self Sameer E. Al-Harthi
2019
Enhancement of doxorubicin cytotoxicity by verapamil in human breast cancer cells.
Al-Harthy, S.E., M.S. Al-Motairi, H.M. Al-Kreathy, F.O. Kamel and M.M. Sayed-Ahmed et al.,
J. Pharm. Res. Int., | Journal Article
Self Sameer E. Al-Harthi
2019
Dimethyl sulfoxide potentiates the anticancer activity of cisplatin against the growth of lung cancer cells.
Osman, A.M.M., S.E. Al-Harthy, R.M. Mohamed, E.A. Huwait, H.M. Al-Kreathy, M. Alkhaled and M.M. Sayed-Ahmed,
Int. J. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2019
Chemosensitizing effects of marine astaxanthin on the anti-cancer activity of doxorubicin in tumor bearing mice.
AlQahtani, A.A., Abdel-Moneim M. Osman, H.M. Al-Kreathy and S.E. Al-Harthy et al.,
Int. J. Cancer Res., | Journal Article
Self Sameer E. Al-Harthi
2019
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
Turcot, V., Y. Lu, H.M. Highland, C. Schurmann and A.E. Justice et al.,
Nat. Genet., | Journal Article
Self Sameer E. Al-Harthi
2018
Differences in the activity of endogenous bone morphogenetic protein signaling impact on the ability of induced pluripotent stem cells to differentiate to corneal epithelial-like cells.
Kamarudin, T.A., S. Bojic, J. Collin, M. Yu and S. Alharthi et al.,
Stem Cells, | Journal Article
Self Sameer E. Al-Harthi
2018
Concise review: Getting to the core of inherited bone marrow failures.
Adam, S., D.M. Sanchis, G. El-Kamah, S. Samarasinghe, S. Alharthi, L. Armstrong and M. Lako,
Stem Cells, | Journal Article
Self Sameer E. Al-Harthi
2017
An induced pluripotent stem cell patient specific model of complement factor H (Y402H) polymorphism displays characteristic features of age-related macular degeneration and indicates a beneficial role for UV light exposure.
Hallam, D., J. Collin, S. Bojic, V. Chichagova and A. Buskin et al.,
Stem Cells, | Journal Article
Self Sameer E. Al-Harthi
2017
Enhancement of efficacy and reduced toxicity of cisplatin through Self Nanoemulsifying Drug Delivery System (SNEDDS).
Osman, A.M.M., H.M. Al-Kreathy, A. Al-Zahrani, O.A. Ahmed and W.S. Ramadan et al.,
Int. J. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2017
Benefits of medication antidote signals for the detection of potential adverse drug reactions over contemporary methods of pharmacovigilance in hospitalized children.
Khan, L.M., F.O. Kamel, H.M. Alkreathy, S.E. Al-Harthi, O.I. Saadah, A.M.M. Osman and M.A. Allibaih,
Int. J. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2017
Allelic variance among ABO blood group genotypes in a population from the Western region of Saudi Arabia.
Mohamed, A.B.O., S.I. Hindawi, S. Al-Harthi, Q. Alam and M.Z. Alam et al.,
Blood Res., | Journal Article
Self Sameer E. Al-Harthi
2016
Dilemmas of the causality assessment tools in the diagnosis of adverse drug reactions.
Khan, L.M., S.E. Al-Harthi, A.M.M. Osman, M.A.A.A. Sattar and A.S. Ali,
Saudi Pharmaceut. J., | Journal Article
Self Sameer E. Al-Harthi
2016
Serum interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah, O.I., S.E. Al-Harthi, J.A. Al-Mughales, Y.Y. Bin-Taleb and R.S. Baeshen,
Int. J. Clin. Exp. Pathol., | Journal Article
Self Sameer E. Al-Harthi
2015
Comparative study of analgesic and anti-inflammatory effects of Commiphora opobalsamum with diclofenac in rodents.
Al-Salmi, A.A., M.A. Sattar, L.M. Khan and S.E. Al-Harthi,
Afr. J. Pharm. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2015
The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats.
Al-Zahrani, Y.A., S.E. Al-Harthi, L.M. Khan, H.M. El-Bassossy, S.M. Edris and M.A.A.A. Sattar,
Saudi Pharmaceut. J., | Journal Article
Self Sameer E. Al-Harthi
2015
Detection of adverse drug reactions by medication antidote signals and comparison of their sensitivity with common methods of ADR detection.
Khan, L.M., S.E. Al-Harthi, H.M. Alkreathy, A.M.M. Osman and A.S. Ali,
Saudi Pharmaceut. J., | Journal Article
Self Sameer E. Al-Harthi
2015
Perceptions and knowledge regarding antimicrobial stewardship among clinicians in Jeddah, Saudi Arabia.
Al-Harthi, S.E., L.M. Khan, A.M. Osman, M.A. Alim, O.I. Saadah, A.A. Almohammadi, F.M. Khan and F.O. Kamel,
Saudi Med. J., | Journal Article
Self Sameer E. Al-Harthi
2015
Modulatory role of resveratrol on cytotoxic activity of cisplatin, sensitization and modification of cisplatin resistance in colorectal cancer cells.
Osman, A.M.M., H.S. Al-Malki, S.E. Al-Harthi, A.A. El-Hanafy, H.M. Elashmaoui and M.F. Elshal,
Mol. Med. Rep., | Journal Article
Self Sameer E. Al-Harthi
2015
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol.
Al-Harthi, S.E., O.M. Alarabi, W.S. Ramadan, M.N. Alaama and H.M. Al-Kreathy et al.,
Mol. Med. Rep., | Journal Article
Self Sameer E. Al-Harthi
2014
Adverse drug reactions in hospitalized pediatric patients of saudi arabian university hospital and impact of pharmacovigilance in reporting ADR.
Khan, L.M., S.E. Al-Harthi and O.I. Saadah,
Saudi Pharm. J., | Journal Article
Self Sameer E. Al-Harthi
2013
MKP-2: Out of the DUSP-bin and back into the limelight.
Lawan, A., E. Torrance, S. Al-Harthi, M. Shweash and S. Alnasser et al.,
Biochem. Soc. Trans., | Journal Article
Self Sameer E. Al-Harthi
2012
Entecavir treatment of children 2-16 years of age with chronic hepatitis B infection.
Saadah, O.I., H.H. Sindi, Y. Bin-Talib, S. Al-Harthi and J. Al-Mughales,
Arab J. Gastroenterol., | Journal Article
Self Sameer E. Al-Harthi
2012
Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line.
Osman, A.M., M.H. Bayoumi, E. Sameer, A. Al-Harthi, A. Zoheir, Damanhouri and M.F. ElShal,
Cancer Cell Int., | Journal Article
Self Sameer E. Al-Harthi
2012
Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan, L.M., S.E. Al-Harthi, O.I. Saadah, A.B. Al-Amoudi and M.I. Sulaiman et al.,
Saudi Med. J., | Journal Article
Self Sameer E. Al-Harthi
2012
Deletion of the Dual Specific Phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP Kinase Phosphatase-2 (MKP-2) in proliferation and cell survival.
Lawan, A., S. Al-Harthi, L. Cadalbert, A.G. McCluskey and M. Shweash et al.,
J. Biol. Chem., | Journal Article
Self Sameer E. Al-Harthi
2011
Over-expression of mitogen-activated protein kinase phosphatase-2 enhances adhesion molecule expression and protects against apoptosis in human endothelial cells.
Al-Mutairi, M., S. Al-Harthi, L. Cadalbert and R. Plevin,
Br. J. Pharmacol., | Journal Article
Self Sameer E. Al-Harthi
2010